sotalol has been researched along with cardiovascular agents in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
| Meyer, C | 1 |
| Alexy, T; Battyany, I; Halmosi, R; Hideg, K; Horvath, B; Kesmarky, G; Marton, Z; Toth, K; Vekasi, J | 1 |
| Aytemir, K; Deniz, A; Yorgun, H | 1 |
| Aström-Lilja, C; Ekman, E; Hägg, S; Odeberg, JM | 1 |
| Andersen, MP; Graff, C; Kanters, JK; Matz, J; Nielsen, J; Struijk, JJ; Toft, E | 1 |
| Mainardi, LT; Rivolta, MW; Sassi, R | 1 |
1 review(s) available for sotalol and cardiovascular agents
| Article | Year |
|---|---|
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
1 trial(s) available for sotalol and cardiovascular agents
| Article | Year |
|---|---|
Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.
Topics: Adolescent; Adult; Algorithms; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Aza Compounds; Cardiovascular Agents; Data Interpretation, Statistical; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Heart; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Risk Assessment; Sotalol; Torsades de Pointes; Young Adult | 2010 |
5 other study(ies) available for sotalol and cardiovascular agents
| Article | Year |
|---|---|
New drugs in the cardiovascular arena.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Cardiovascular Diseases; Humans; Quinolines; Sotalol; Vasodilator Agents | 1993 |
Scavenger effect of experimental and clinically used cardiovascular drugs.
Topics: Anti-Arrhythmia Agents; Antioxidants; Carbazoles; Cardiovascular Agents; Carvedilol; Erythrocytes; Free Radical Scavengers; Humans; Indoles; Male; Methylphenazonium Methosulfate; Mexiletine; Propanolamines; Pyrroles; Sotalol | 2001 |
Cardiogenic shock secondary to combination of diltiazem and sotalol.
Topics: Cardiovascular Agents; Diltiazem; Drug Therapy, Combination; Humans; Male; Middle Aged; Shock, Cardiogenic; Sotalol; Treatment Outcome | 2008 |
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Cardiovascular Agents; Citalopram; Databases, Factual; Drug Labeling; Female; Heart Diseases; Humans; Long QT Syndrome; Male; Middle Aged; Risk Factors; Sex Factors; Sotalol; Sweden; Torsades de Pointes | 2008 |
Quantification of ventricular repolarization heterogeneity during moxifloxacin or sotalol administration using [Formula: see text]-index.
Topics: Cardiovascular Agents; Electrocardiography; Fluoroquinolones; Heart Rate; Humans; Moxifloxacin; Placebo Effect; Retrospective Studies; Signal Processing, Computer-Assisted; Sotalol; Ventricular Function | 2015 |